|Articles|November 2, 2003
- Pharmaceutical Technology-11-02-2003
- Volume 27
- Issue 11
FDA Seeks Risk-Based Inspection Program
Author(s)Jill Wechsler
FDA's new policies intend to make GMP inspections more efficient and apply to stricter rules to high-risk products and processes.
Advertisement
Articles in this issue
about 22 years ago
FDA Will Drive Changes for Contract Businessabout 22 years ago
In the Spotlight--Decemberabout 22 years ago
Novemember 2003about 22 years ago
Routine Sample Size for a Retest Procedureabout 22 years ago
November 2003about 22 years ago
Clearing Regulatory Hurdlesabout 22 years ago
Improving Protein Capture for Transgenic Drug ProcessingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA, Duke University Planning Epinephrine Access Workshop for December
2
How ten23 health is Advancing Patient-Centric Drug Delivery
3
Drug Solutions Podcast: Innovations in Orphan Drugs for Rare Diseases
4
Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part II
5
